IMGO

Imago BioSciences

This biopharmaceutical company develops small molecule inhibitors to treat patients with myeloproliferative neoplasms and other bone marrow diseases.

Kronos Bio

This biopharmaceutical company develops small molecule therapeutics targeting transcription factors for patients with cancer and autoimmune diseases.

NKIO

This company develops natural killer cell therapies and small molecule medicines to treat solid tumours for patients with cancer and inflammatory diseases.

ALXO

This biopharmaceutical company develops immune system therapies to treat cancer patients with solid tumors and hematologic malignancies.

Constellation Pharmaceuticals

This biopharmaceutical company develops small-molecule epigenetics therapies to treat patients with blood cancers and solid tumours.

Biopharmaceutical company

This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.

Oncopeptides AB

This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.

VTYX

This biopharmaceutical company develops oral small-molecule medicines for patients with autoimmune, inflammatory, cardiovascular and neurodegenerative diseases.